Medicare Part D and insulin affordability - the devil is in the details

New England Journal of Medicine

13 May 2020 - Millions of Americans rely on insulin, and reports about cost-related underuse and subsequent deaths, primarily among uninsured or underinsured people, have proliferated in the popular press. 

But affordability of insulin may also be a concern for Medicare beneficiaries.

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Market access